Last deal

$2.2M
Local Amount - CAD 2.9M

Amount

Post-IPO Equity

Stage

16.01.2024

Date

13

all rounds

$243.9M

Total amount

General

About Company
Profound Medical Inc is a medical device company that revolutionizes prostate care with its Magnetic Resonance guided ablation procedure.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Profound

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

By combining real-time MR guidance, ultrasound energy, intelligent software, and robotics, Profound Medical aims to meet the unmet needs of patients and clinicians in various anatomies and disease states. Their mission is to redefine the standard of care by providing precise and non-invasive ablative tools, allowing clinicians to confidently ablate tissue. With their TULSA-PRO system, which utilizes real-time MRI and robotically driven thermal ultrasound, the company offers customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue. This system integrates with existing MRI scanners, leveraging the healthcare system's infrastructure and providing safe and effective treatment options for patients.